• 1
    Heldin CH, Miyazono K, Ten Dijke P. TGF-β signalling from cell membrane to nucleus through SMAD proteins. Nature 1997; 390: 46571.
  • 2
    Shi Y, Massague J. Mechanisms of TGF-β signaling from cell membrane to the nucleus. Cell 2003; 113: 685700.
  • 3
    Levy L, Hill CS. Smad4 dependency defines two classes of transforming growth factor β (TGF-β) target genes and distinguishes TGF-β-induced epithelial-mesenchymal transition from its antiproliferative and migratory responses. Mol Cell Biol 2005; 25: 810825.
  • 4
    Derynck R, Akhurst RJ, Balmain A. TGF-β signaling in tumor suppression and cancer progression. Nat Genet 2001; 29: 11729.
  • 5
    Levy L, Hill CS. Alterations in components of the TGF-β superfamily signaling pathways in human cancer. Cytokine Growth Factor Rev 2006; 17: 4158.
  • 6
    Qiao W, Li AG, Owens P, Xu X, Wang XJ, Deng CX. Hair follicle defects and squamous cell carcinoma formation in Smad4 conditional knockout mouse skin. Oncogene 2006; 25: 20717.
  • 7
    Bardeesy N, Cheng KH, Berger JH et al. Smad4 is dispensable for normal pancreas development yet critical in progression and tumor biology of pancreas cancer. Genes Dev 2006; 20: 313046.
  • 8
    Yang L, Mao C, Teng Y et al. Targeted disruption of Smad4 in mouse epidermis results in failure of hair follicle cycling and formation of skin tumors. Cancer Res 2005; 65: 86718.
  • 9
    Jazag A, Ijichi H, Kanai F et al. Smad4 silencing in pancreatic cancer cell lines using stable RNA interference and gene expression profiles induced by transforming growth factor-β. Oncogene 2005; 24: 66271.
  • 10
    Koinuma D, Tsutsumi S, Kamimura N et al. Chromatin immunoprecipitation on microarray analysis of Smad2/3 binding sites reveals roles of ETS1 and TFAP2A in transforming growth factor β signaling. Mol Cell Biol 2009; 29: 17286.
  • 11
    Boukamp P, Petrussevska RT, Breitkreutz D, Hornung J, Markham A, Fusenig NE. Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line. J Cell Biol 1988; 106: 76171.
  • 12
    Geng Y, Weinberg RA. Transforming growth factor β effects on expression of G1 cyclins and cyclin-dependent protein kinases. Proc Natl Acad Sci U S A 1993; 90: 103159.
  • 13
    Tojo M, Hamashima Y, Hanyu A et al. The ALK-5 inhibitor A-83-01 inhibits Smad signaling and epithelial-to-mesenchymal transition by transforming growth factor-β. Cancer Sci 2005; 96: 791800.
  • 14
    Ehata S, Hanyu A, Hayashi M et al. Transforming growth factor-β promotes survival of mammary carcinoma cells through induction of antiapoptotic transcription factor DEC1. Cancer Res 2007; 67: 9694703.
  • 15
    Kaneshiro K, Tsutsumi S, Tsuji S, Shirahige K, Aburatani H. An integrated map of p53-binding sites and histone modification in the human ENCODE regions. Genomics 2007; 89: 17888.
  • 16
    Wendt KS, Yoshida K, Itoh T et al. Cohesin mediates transcriptional insulation by CCCTC-binding factor. Nature 2008; 451: 796801.
  • 17
    Johnson WE, Li W, Meyer CA et al. Model-based analysis of tiling-arrays for ChIP-chip. Proc Natl Acad Sci U S A 2006; 103: 1245762.
  • 18
    Ji X, Li W, Song J, Wei L, Liu XS. CEAS: cis-regulatory element annotation system. Nucleic Acids Res 2006; 34: W5514.
  • 19
    Crooks GE, Hon G, Chandonia JM, Brenner SE. WebLogo: a sequence logo generator. Genome Res 2004; 14: 118890.
  • 20
    Koinuma D, Shinozaki M, Komuro A et al. Arkadia amplifies TGF-β superfamily signalling through degradation of Smad7. EMBO J 2003; 22: 645870.
  • 21
    Miyazawa K, Shinozaki M, Hara T, Furuya T, Miyazono K. Two major Smad pathways in TGF-β superfamily signalling. Genes Cells 2002; 7: 1191204.
  • 22
    Liu IM, Schilling SH, Knouse KA, Choy L, Derynck R, Wang XF. TGFβ-stimulated Smad1/5 phosphorylation requires the ALK5 L45 loop and mediates the pro-migratory TGFβ switch. EMBO J 2009; 28: 8898.
  • 23
    Daly AC, Randall RA, Hill CS. Transforming growth factor β-induced Smad1/5 phosphorylation in epithelial cells is mediated by novel receptor complexes and is essential for anchorage-independent growth. Mol Cell Biol 2008; 28: 6889902.
  • 24
    Goumans MJ, Valdimarsdottir G, Itoh S, Rosendahl A, Sideras P, Ten Dijke P. Balancing the activation state of the endothelium via two distinct TGF-β type I receptors. EMBO J 2002; 21: 174353.
  • 25
    Zhang Y, Feng XH, Derynck R. Smad3 and Smad4 cooperate with c-Jun/c-Fos to mediate TGF-β-induced transcription. Nature 1998; 394: 90913.
  • 26
    Hahn SA, Schutte M, Hoque AT et al. DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1. Science 1996; 271: 3503.
  • 27
    David L, Mallet C, Mazerbourg S, Feige JJ, Bailly S. Identification of BMP9 and BMP10 as functional activators of the orphan activin receptor-like kinase 1 (ALK1) in endothelial cells. Blood 2007; 109: 195361.
  • 28
    Yu PB, Hong CC, Sachidanandan C et al. Dorsomorphin inhibits BMP signals required for embryogenesis and iron metabolism. Nat Chem Biol 2008; 4: 3341.
  • 29
    Descargues P, Sil AK, Sano Y et al. IKKα is a critical coregulator of a Smad4-independent TGFβ-Smad2/3 signaling pathway that controls keratinocyte differentiation. Proc Natl Acad Sci U S A 2008; 105: 248792.
  • 30
    Hoot KE, Lighthall J, Han G et al. Keratinocyte-specific Smad2 ablation results in increased epithelial-mesenchymal transition during skin cancer formation and progression. J Clin Invest 2008; 118: 272232.
  • 31
    Jinno S, Yageta M, Nagata A, Okayama H. Cdc6 requires anchorage for its expression. Oncogene 2002; 21: 177784.
  • 32
    Miki T, Smith CL, Long JE, Eva A, Fleming TP. Oncogene ect2 is related to regulators of small GTP-binding proteins. Nature 1993; 362: 4625.